Our expertise and resources enable the in-house production of peptides, oligonucleotides, and recombinant proteins for diagnostic testing applications. These molecular reagents interact with specific biological targets within the testing process to enable accurate detection and measurement.
Our automated processes, scalable production systems, and advanced testing and purification capabilities support rapid development and consistent performance across reagent types.
This means we accelerate development timelines, enable rapid iteration, and ensure consistent quality without reliance on external partners - reducing supply chain risk, lowering costs, and providing greater control from early-stage research through to manufacturing.
Designed for scale, our molecular reagent capability supports production for more than one million devices annually, with capacity expandable through collaborative partnerships. This flexible approach enables efficient scale-up and reliable supply for high-volume diagnostic deployment.
